Commodore Capital LP

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 45 securities · passive
JATT III Acquisition Corp 13G/A
JTTT · G5080G109
4.5% 11/16/2026
Event 9/30/2026
Research Alliance Corp IV 13G/A
RACD · G75228109
0% 11/16/2026
Event 9/30/2026
Amylyx Pharmaceuticals, Inc. 13G/A
AMLX · 03237H101
1.6% 11/16/2026
Event 9/30/2026
LB Pharmaceuticals Inc 13G/A
LBRX · 50180M108
5.8% 11/16/2026
Event 9/30/2026
Vistagen Therapeutics, Inc. 13G/A
VTGN · 92840H400
3.7% 11/16/2026
Event 9/30/2026
EyePoint, Inc. 13G/A
EYPT · 30233G209
0% 11/16/2026
Event 9/30/2026
Perspective Therapeutics, Inc. 13G/A
CATX · 46489V302
5.5% 11/16/2026
Event 9/30/2026
AN2 Therapeutics, Inc. 13G/A
ANTX · 037326105
9.9% 11/16/2026
Event 9/30/2026
InflaRx N.V. 13G/A
IFRX · N44821101
6.3% 11/16/2026
Event 9/30/2026
Mentari Therapeutics, Inc. 13G
587157108
5.6% 11/13/2026
Event 11/6/2026
Sagimet Biosciences Inc. 13G
SGMT · 786700104
7.6% 10/7/2026
Event 9/30/2026
Surrozen, Inc./DE 13G
SRZN · 86889P208
7.5% 10/1/2026
Event 9/24/2026
Palisade Bio, Inc. 13G/A
PALI · 696389402
0% 8/14/2026
Event 6/30/2026
JATT II Acquisition Corp. 13G/A
JATT · G50765109
0% 8/14/2026
Event 6/30/2026
Immunic, Inc. 13G/A
IMUX · 4525EP200
9.9% 8/14/2026
Event 6/30/2026
Karyopharm Therapeutics Inc. 13G/A
KPTI · 48576U205
0% 8/14/2026
Event 6/30/2026
Relay Therapeutics, Inc. 13G/A
RLAY · 75943R102
5.5% 8/14/2026
Event 6/30/2026
SAB Biotherapeutics, Inc. 13G/A
SABS · 78397T202
9.9% 8/14/2026
Event 6/30/2026
Definium Therapeutics, Inc. 13G/A
DFTX · 24477V105
1.8% 8/14/2026
Event 6/30/2026
Avalo Therapeutics, Inc. 13G
AVTX · 05338F306
9.9% 6/18/2026
Event 6/11/2026
Editas Medicine, Inc. 13G
EDIT · 28106W103
9.9% 6/2/2026
Event 5/26/2026
Research Alliance Corp III 13G
RACC · G75226103
5.5% 5/28/2026
Event 5/20/2026
Enliven Therapeutics, Inc. 13G/A
ELVN · 29337E102
7.7% 5/15/2026
Event 3/31/2026
PepGen Inc. 13G/A
PEPG · 713317105
6.5% 5/15/2026
Event 3/31/2026
Tyra Biosciences, Inc. 13G/A
TYRA · 90240B106
4.2% 5/15/2026
Event 3/31/2026
Inhibikase Therapeutics, Inc. 13G/A
IKT · 45719W205
9.9% 5/15/2026
Event 3/31/2026
Alto Neuroscience, Inc. 13G/A
ANRO · 02157Q109
9.9% 5/15/2026
Event 3/31/2026
Relmada Therapeutics, Inc. 13G
RLMD · 75955J402
5.1% 5/4/2026
Event 4/27/2026
Immunic, Inc. 13G
IMUX · 4525EP101
Amended under CUSIP 4525EP200 on 8/14/2026
9.9% 2/24/2026
Event 2/17/2026
Cogent Biosciences, Inc. 13G/A
COGT · 19240Q201
1.8% 2/17/2026
Event 12/31/2025
Perceptive Capital Solutions Corp 13G/A
PCSC · G70077105
0% 2/17/2026
Event 12/31/2025
Terns Pharmaceuticals, Inc. 13G/A
TERN · 880881107
1.4% 2/17/2026
Event 12/31/2025
Bright Minds Biosciences Inc. 13G/A
DRUG · 10919W405
0.3% 2/17/2026
Event 12/31/2025
Century Therapeutics, Inc. 13G
IPSC · 15673T100
7.1% 1/16/2026
Event 1/9/2026
Viridian Therapeutics, Inc.\DE 13G/A
VRDN · 92790C104
3.9% 11/14/2025
Event 9/30/2025
Celldex Therapeutics, Inc. 13G/A
CLDX · 15117B202
4.6% 11/14/2025
Event 9/30/2025
Nurix Therapeutics, Inc. 13G/A
NRIX · 67080M103
4.9% 11/14/2025
Event 9/30/2025
Cidara Therapeutics, Inc. 13G/A
CDTX · 171757206
2.0% 11/14/2025
Event 9/30/2025
Assembly Biosciences, Inc. 13G
ASMB · 045396207
9.9% 8/15/2025
Event 8/8/2025
Solid Biosciences Inc. 13G/A
SLDB · 83422E204
0% 8/14/2025
Event 6/30/2025
Neurogene Inc. 13G/A
NGNE · 64135M105
3.0% 8/14/2025
Event 6/30/2025
Merus N.V. 13G/A
MRUS · N5749R100
4.7% 8/14/2025
Event 6/30/2025
Cardiff Oncology, Inc. 13G/A
CRDF · 14147L108
0% 8/14/2025
Event 6/30/2025
Nkarta, Inc. 13G/A
NKTX · 65487U108
0.5% 2/14/2025
Event 12/31/2024
Celcuity Inc. 13G/A
CELC · 15102K100
2.9% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.